52 Week Low Stocks Based on AI: Returns up to 18.26% in 7 Days

52 Week Low Stocks

The 52 Week Low Stocks Package is designed for investors and analysts who need predictions for stocks currently at their 52-week low price level, offering the best market opportunities based on algo-trading. It includes 20 stocks with bullish and bearish signals and indicates the best stocks to invest in:

  • 52 Weeks Low Top 10 stocks for the long position
  • 52 Weeks Low Top 10 stocks for the short position

52 Week Low Stocks
Package Name: 52 Week Low Stocks
Recommended Positions: Long
Forecast Length: 7 Days (10/20/2019 – 10/28/2019)
I Know First Average: 4.44%
52 Week Low Stocks
52 Week Low Stocks chart

During the 7 Days forecasted period several picks in the 52 Week Low Stocks Package saw significant returns. The algorithm had correctly predicted 7 out 10 returns. CLVS was the highest-earning trade with a return of 18.26% in 7 Days. The suggested trades for BERY and ANTM also had notable 7 Days yields of 8.65% and 7.33%, respectively. The package itself saw an overall return of 4.44%, providing investors with a 2.66% premium above the S&P 500’s return of 1.78% for the same time period.

Clovis Oncology, Inc., incorporated on April 20, 2009, is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product candidates include Rociletinib, Rubraca (Rucaparib) and Lucitanib. Its commercial product Rucaparib is an oral, small molecule poly adenosine diphosphate (ADP)-ribose polymerase (PARP), inhibitor of PARP1, PARP2 and PARP3 approved in the United States by the Food and Drug Administration (FDA), as monotherapy for the treatment of patients with deleterious breast cancer (BRCA) (human genes associated with the repair of damaged deoxyribonucleic acid (DNA)) mutation (germline and/or somatic) associated advanced ovarian cancer, who have been treated with two or more chemotherapies, and selected for therapy based on an FDA-approved companion diagnostic for Rubraca.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.